Combined Cytotoxic Effect of Inhibitors of Proteostasis on Human Colon Cancer Cells

Despite significant progress in the diagnosis and treatment of colorectal cancer, drug resistance continues to be a major limitation of therapy. In this regard, studies aimed at creating combination therapy are gaining popularity. One of the most promising adjuvants are inhibitors of the proteostasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikotina, Alina D., Vladimirova, Snezhana A., Kokoreva, Nadezhda E., Komarova, Elena Y., Aksenov, Nikolay D., Efremov, Sergey, Leonova, Elizaveta, Pavlov, Rostislav, Kartsev, Viktor G., Zhang, Zhichao, Margulis, Boris A., Guzhova, Irina V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331496/
https://www.ncbi.nlm.nih.gov/pubmed/35893747
http://dx.doi.org/10.3390/ph15080923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331496/
https://www.ncbi.nlm.nih.gov/pubmed/35893747
http://dx.doi.org/10.3390/ph15080923

Ejemplares similares